VERICI DX PLC

Declaration of Voting Results & Voting Rights Announcements • May 27, 2025

National Storage Mechanism | Additional information

RNS Number : 2753K

Verici Dx PLC

27 May 2025

Verici Dx plc

("Verici Dx" or the "Company")

Result of General Meeting

Verici Dx Plc, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that at the General Meeting ("GM") held earlier today, all resolutions, as set out in the GM notice published on 9 May 2025, were duly passed on a poll. Resolution 1 was passed as an ordinary resolution and resolution 2 was passed as a special resolution.

The voting results of the GM were as follows:

	In Favour		Against		Withheld
Resolution	Votes	%	Votes	%	Votes
1	112,453,134	99.96	47,616	0.04	23,820
2	112,380,881	99.89	119,738	0.11	23,951

Verici Dx plc	www.vericidx.com
Sara Barrington, CEO	Via Walbrook PR
Singer Capital Markets (Nominated Adviser and Broker)		Tel: +44 (0)20 7496 3000
Phil Davies / Sam Butcher
Walbrook PR (Media & Investor Relations)	Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com
Alice Woodings / Paul McManus	Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMPPUGCAUPAGWM